Investors

Press Releases

Press Releases

April 19, 2021
REDWOOD CITY, Calif. , April 19, 2021 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company” or “Allakos”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today announced that Baird Radford has been appointed Chief

Data Provided by Refinitiv. Minimum 15 minutes delayed.